These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7856296)
61. Immunization of young infants with Edmonston-Zagreb measles vaccine. Markowitz LE; Bernier RH Pediatr Infect Dis J; 1987 Sep; 6(9):809-12. PubMed ID: 3313247 [TBL] [Abstract][Full Text] [Related]
62. Comparative results of the immunogenicity of Edmonston-Zagreb and Schwartz measles vaccines administered to 60 Egyptian infants. Abdel Hadi S; Hassan R; Hosny M; Lotfy S; Mansour MT; Aly N; Attia M J Egypt Public Health Assoc; 1992; 67(1-2):27-36. PubMed ID: 1295948 [TBL] [Abstract][Full Text] [Related]
63. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age. Ceyhan M; Kanra G; Erdem G; Kanra B Vaccine; 2001 Aug; 19(31):4473-8. PubMed ID: 11483273 [TBL] [Abstract][Full Text] [Related]
64. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy. Aaby P; Jensen TG; Hansen HL; Kristiansen H; Thårup J; Poulsen A; Sodemann M; Jakobsen M; Knudsen K; Clotilde da Silva M Lancet; 1988 Oct; 2(8615):809-11. PubMed ID: 2902263 [TBL] [Abstract][Full Text] [Related]
65. Measles vaccination before nine months. George K; Joseph A; Muliyil J; Abraham S; Bhattacharji S; John KR Trop Med Int Health; 1998 Sep; 3(9):751-6. PubMed ID: 9754672 [TBL] [Abstract][Full Text] [Related]
66. Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age. Carson MM; Spady DW; Beeler JA; Krezolek MP; Audet S; Pabst HF Vaccine; 2005 May; 23(25):3247-55. PubMed ID: 15837229 [TBL] [Abstract][Full Text] [Related]
67. Determination Factors Associated with Immune Responses Towards First Dose Edmonston-Zagreb (EZ) Measles Vaccine in Indonesian Infants. Teni Nurlatifah HR; Barlianto W; Wiyasa WA; Kusuma C; Sari TL; Bachtiar NS Med Arch; 2021 Oct; 75(5):335-339. PubMed ID: 35169353 [TBL] [Abstract][Full Text] [Related]
68. Immune status following measles vaccination in infants and evaluation for the need of revaccination. Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977 [TBL] [Abstract][Full Text] [Related]
70. Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants. Kiepiela P; Coovadia HM; Loening WE; Coward P; Botha G; Hugo J; Becker PJ Bull World Health Organ; 1991; 69(2):221-7. PubMed ID: 1860150 [TBL] [Abstract][Full Text] [Related]
71. Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection. Khanum S; Uddin N; Garelick H; Mann G; Tomkins A Lancet; 1987 Jan; 1(8525):150-3. PubMed ID: 2879981 [TBL] [Abstract][Full Text] [Related]
72. Measles vaccination of Thai infants by intranasal and subcutaneous routes: possible interference from respiratory infections. Simasathien S; Migasena S; Bellini W; Samakoses R; Pitisuttitham P; Bupodom W; Heath J; Anderson L; Bennett J Vaccine; 1997 Feb; 15(3):329-34. PubMed ID: 9139495 [TBL] [Abstract][Full Text] [Related]
73. Antibody response after measles immunization. Ariyasriwatana C; Kalayanarooj S; Pattamadilok S J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170 [TBL] [Abstract][Full Text] [Related]
74. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa. Benn CS; Aaby P; Balé C; Olsen J; Michaelsen KF; George E; Whittle H Lancet; 1997 Jul; 350(9071):101-5. PubMed ID: 9228962 [TBL] [Abstract][Full Text] [Related]
75. Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rate. Aaby P; Knudsen K; Whittle H; Lisse IM; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U J Pediatr; 1993 Jun; 122(6):904-8. PubMed ID: 8501567 [TBL] [Abstract][Full Text] [Related]
76. Revaccination against measles--a pilot study. Watson GI; Nichols JA; Robshaw JR J R Coll Gen Pract; 1975 Dec; 25(161):863-73. PubMed ID: 1223275 [TBL] [Abstract][Full Text] [Related]
78. Measles immunisation before the age of nine months? Position statement by the expanded programme on immunisation of the World Health Organisation. Lancet; 1988 Dec; 2(8624):1356-7. PubMed ID: 2904064 [TBL] [Abstract][Full Text] [Related]
79. Strains of measles vaccine differ in their ability to replicate in an damage human thymus. Valsamakis A; Kaneshima H; Griffin DE J Infect Dis; 2001 Feb; 183(3):498-502. PubMed ID: 11133383 [TBL] [Abstract][Full Text] [Related]
80. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Miller E; Hill A; Morgan-Capner P; Forsey T; Rush M Vaccine; 1995 Jun; 13(9):799-802. PubMed ID: 7483800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]